Associated Papers
E-cadherin (CDH1) gene -160C/A polymorphism and the risk of colorectal cancer: A meta-analysis involving 17,291 subjects.
Ye CC et al.
The Journal of Gene Medicine, 2021
Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2019
Clinical and biological significance of a - 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma.
Zhang B et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018
The E-cadherin (CDH1) -160C>A polymorphism associated with gastric cancer among Asians but not Europeans.
Wang Q et al.
Dna and Cell Biology, 2011
E-cadherin-160 C/A promoter polymorphism and risk of pancreatic carcinoma in Chinese population.
Fei Y et al.
Cancer Genetics and Cytogenetics, 2010
Hereditary diffuse gastric cancer.
Schrader K et al.
Cancer Treatment and Research, 2010
DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.
Ma X et al.
Bju International, 2008
SNPs associated with prostate cancer risk and prognosis.
Naylor SL
Frontiers in Bioscience : a Journal and Virtual Library, 2007
Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.
Sarrió D et al.
International Journal of Cancer, 2003
Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer.
Porter TR et al.
Oncogene, 2002
The G/A nucleotide change at cDNA position 2494 in the E-cadherin gene (CDH1): analysis in Italian patients.
Ruzzo A et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 0
E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer.
de Lima JM et al.
The International Journal of Biological Markers, 0
Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A et al.
Journal of Cancer Research and Therapeutics, 0